1. Home
  2. CGEM vs CAL Comparison

CGEM vs CAL Comparison

Compare CGEM & CAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • CAL
  • Stock Information
  • Founded
  • CGEM 2016
  • CAL 1878
  • Country
  • CGEM United States
  • CAL United States
  • Employees
  • CGEM N/A
  • CAL N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • CAL Shoe Manufacturing
  • Sector
  • CGEM Health Care
  • CAL Consumer Discretionary
  • Exchange
  • CGEM Nasdaq
  • CAL Nasdaq
  • Market Cap
  • CGEM 955.5M
  • CAL 1.1B
  • IPO Year
  • CGEM 2021
  • CAL N/A
  • Fundamental
  • Price
  • CGEM $12.54
  • CAL $31.53
  • Analyst Decision
  • CGEM Strong Buy
  • CAL Hold
  • Analyst Count
  • CGEM 7
  • CAL 2
  • Target Price
  • CGEM $31.67
  • CAL $32.50
  • AVG Volume (30 Days)
  • CGEM 537.5K
  • CAL 467.4K
  • Earning Date
  • CGEM 11-07-2024
  • CAL 12-05-2024
  • Dividend Yield
  • CGEM N/A
  • CAL 0.89%
  • EPS Growth
  • CGEM N/A
  • CAL 12.22
  • EPS
  • CGEM N/A
  • CAL 4.63
  • Revenue
  • CGEM N/A
  • CAL $2,801,542,000.00
  • Revenue This Year
  • CGEM N/A
  • CAL N/A
  • Revenue Next Year
  • CGEM N/A
  • CAL $3.30
  • P/E Ratio
  • CGEM N/A
  • CAL $6.82
  • Revenue Growth
  • CGEM N/A
  • CAL N/A
  • 52 Week Low
  • CGEM $7.64
  • CAL $27.67
  • 52 Week High
  • CGEM $30.19
  • CAL $44.51
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 31.78
  • CAL 54.40
  • Support Level
  • CGEM $12.04
  • CAL $29.20
  • Resistance Level
  • CGEM $17.50
  • CAL $32.77
  • Average True Range (ATR)
  • CGEM 1.12
  • CAL 1.00
  • MACD
  • CGEM -0.36
  • CAL 0.19
  • Stochastic Oscillator
  • CGEM 9.15
  • CAL 68.77

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications.

About CAL Caleres Inc.

Caleres Inc is a footwear retailer in the United States. The Company's business are organized into two reportable segments are famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of famous Footwear retail stores, famousfootwear.com and famousfootwear.ca. The Brand Portfolio segment offers retailers and consumers a carefully cultivated portfolio of top brands. This segment is comprised of wholesale operations that designs, develops, sources, manufactures, markets and distributes branded, licensed and private-label footwear to online retailers, national chains, department stores, mass merchandisers and independent retailers, as well as Company owned famous Footwear, Sam Edelman, Naturalizer and Allen Edmonds stores and e-commerce businesses.

Share on Social Networks: